India refuses patent protection for two key HIV drugs
Hiv/Aids Policy and Law Review 14(2): 28-29
2009
ISSN/ISBN: 1712-624X PMID: 20225511 Document Number: 209979
In September 2009, the Indian Patent Office (IPO) rejected applications for patents from two U.S. pharmaceutical companies for tenofovir and darunavir.
Document emailed within 1 workday
Related Documents
Menghaney, L. 2013: Patent injustice: how India brought cheap HIV drugs to Africa Bmj 347: F7013Pavento, L.C.; Greene, J.L.; McDonald, J.K. 2003: International patent protection for HIV-related therapies: patent attorney's perspective Emory international law review 17(2): 919-931
Konieczny, M.T. 2000: Patent protection of pharmaceuticals Acta Poloniae Pharmaceutica 57 Suppl: 84-87
Watson, R. 2010: European Commission targets drug firms over illegal patent protection Bmj 340: C268
Hegde, G.T.; Murali, K.S.; Bhat, D.M.; Bhat, P.R.; Ravindranath, N.H. 2005: Effect of protection on regeneration in some selected village forests under community protection in Uttara Kannada district, Karnataka, India Current Science 88(5): 810-815
McGettigan, P.; Roderick, P.; Mahajan, R.; Kadam, A.; Pollock, A.M. 2015: Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs PLOS Medicine 12(5): E1001826; Discussion E1001826
Khodakov, M.B.; Borzunov, E.E. 1971: Cooperation in the problem of international non-patent names of drugs Farmatsevtychnyi Zhurnal 26(1): 78-80
Ennet, D.; Hauschild, J.; Pank, F. 1978: Residues of plant protection products and agents for controlling biological processes in drugs of the pharmacopoeia of the GDR, edition 2. 1. General aspects of packaging of plant protection products and agents for controlling biological processes in botanical drugs in the GDR Die Pharmazie 33(11): 697-705
Guo, D.; Nashunchaoketu; Wang, J.; Liu, X.; Wu, S.; Zhao, X.; Yang, B. 2009: Simultaneous determination of four highly polar anti-diabetic drugs in Chinese traditional patent medicines using high performance liquid chromatography Se Pu 27(2): 211-215
Rieger, H.J. 1984: Withdrawal of drugs for the patient's own protection Deutsche Medizinische Wochenschrift 109(48): 1860
Laudanno, O.M.; Cesolari, J.é A.M. 2006: Angiotensin Ii AT1 receptor antagonists as antiinflammatory and gastric protection drugs Acta Gastroenterologica Latinoamericana 36(2): 76-80
Peters, P.W.; Verburg, H. 1987: The importance of health protection of the consumer in relation to veterinary drugs Tijdschrift Voor Diergeneeskunde 112(8): 486-490
Meldrum, B. 1990: Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission Cerebrovascular and Brain Metabolism Reviews 2(1): 27-57
Biswajit Ghosh; Tanima Choudhuri 2011: Legal Protection Against Domestic Violence in India: Scope and Limitations Journal of Family Violence 26(4): 319-330
Singh, K.; Shetty, S.; Bhat, N.; Sharda, A.; Agrawal, A.; Chaudhary, H. 2010: Awareness of Consumer Protection Act among Doctors in Udaipur City, India Journal of Dentistry 7(1): 19-23
Lewis, R.P. 1990: Digitalis: a drug that refuses to die Critical Care Medicine 18(1 Pt 2): S5-13
Halliburton, M. 2009: Drug resistance, patent resistance: Indian pharmaceuticals and the impact of a new patent regime Global Public Health 4(6): 515-527
Davies, D.A. 1974: The combined effect of drugs and tumor-specific antibodies in protection against a mouse lymphoma Cancer Research 34(11): 3040-3043
Sharma, D.G. 1967: The Problems of Forest Protection in India with Special Reference to Madhya Pradesh Indian Forester 93(6): 407-410
Tammelleo, A.D. 1986: Nurse refuses to "float": sunk Regan Report on Nursing Law 27(7): 1